Luminex Gets Emergency Authorization From FDA For Zika Detection

Austin-based Luminex, which develops molecular testing equipment, reported this morning that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), for a test designed to test for the Zika virus. According to the company, the new test works to detect viral Zika RNA in serum, plasma, or urine, detecting the virus less than 14 days after symptom onset. The company is one of a number of companies which the FDA has provided emergency authorizations for, as it ramps up efforts to better control the disease. The FDA has provided emergency authorizations to at least four other PCR and molecular testing providers for Zika testing.